139 related articles for article (PubMed ID: 21932096)
1. Hippocampal atrophy as a surrogate of neuronal involvement in Fabry disease.
Fellgiebel A; Wolf DO; Kolodny E; Müller MJ
J Inherit Metab Dis; 2012 Mar; 35(2):363-7. PubMed ID: 21932096
[TBL] [Abstract][Full Text] [Related]
2. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
[TBL] [Abstract][Full Text] [Related]
3. White matter lesions characterise brain involvement in moderate to severe chronic obstructive pulmonary disease, but cerebral atrophy does not.
Spilling CA; Jones PW; Dodd JW; Barrick TR
BMC Pulm Med; 2017 Jun; 17(1):92. PubMed ID: 28629404
[TBL] [Abstract][Full Text] [Related]
4. Neurological complications of Anderson-Fabry disease.
Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Arnao V; Licata G; Pinto A
Curr Pharm Des; 2013; 19(33):6014-30. PubMed ID: 23448452
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychiatric symptoms and brain structural alterations in Fabry disease.
Schermuly I; Müller MJ; Müller KM; Albrecht J; Keller I; Yakushev I; Beck M; Fellgiebel A
Eur J Neurol; 2011 Feb; 18(2):347-353. PubMed ID: 20636371
[TBL] [Abstract][Full Text] [Related]
6. Association of white-matter lesions with brain atrophy markers: the three-city Dijon MRI study.
Godin O; Maillard P; Crivello F; Alpérovitch A; Mazoyer B; Tzourio C; Dufouil C
Cerebrovasc Dis; 2009; 28(2):177-84. PubMed ID: 19556771
[TBL] [Abstract][Full Text] [Related]
7. Eight-Year Follow-Up of Neuropsychiatric Symptoms and Brain Structural Changes in Fabry Disease.
Lelieveld IM; Böttcher A; Hennermann JB; Beck M; Fellgiebel A
PLoS One; 2015; 10(9):e0137603. PubMed ID: 26340726
[TBL] [Abstract][Full Text] [Related]
8. Subjective cognitive failures and hippocampal volume in elderly with white matter lesions.
van Norden AG; Fick WF; de Laat KF; van Uden IW; van Oudheusden LJ; Tendolkar I; Zwiers MP; de Leeuw FE
Neurology; 2008 Oct; 71(15):1152-9. PubMed ID: 18838662
[TBL] [Abstract][Full Text] [Related]
9. Influences of lobar gray matter and white matter lesion load on cognition and mood.
Mueller SG; Mack WJ; Mungas D; Kramer JH; Cardenas-Nicolson V; Lavretsky H; Greene M; Schuff N; Chui HC; Weiner MW
Psychiatry Res; 2010 Feb; 181(2):90-6. PubMed ID: 20074914
[TBL] [Abstract][Full Text] [Related]
10. Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study.
Damjanovic D; Valsasina P; Rocca MA; Stromillo ML; Gallo A; Enzinger C; Hulst HE; Rovira A; Muhlert N; De Stefano N; Bisecco A; Fazekas F; Arévalo MJ; Yousry TA; Filippi M
AJNR Am J Neuroradiol; 2017 Jan; 38(1):18-24. PubMed ID: 27686487
[TBL] [Abstract][Full Text] [Related]
11. Enzyme replacement therapy stabilized white matter lesion progression in Fabry disease.
Fellgiebel A; Gartenschläger M; Wildberger K; Scheurich A; Desnick RJ; Sims K
Cerebrovasc Dis; 2014; 38(6):448-56. PubMed ID: 25502511
[TBL] [Abstract][Full Text] [Related]
12. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of different MRI and MR angiography measures in Fabry disease.
Fellgiebel A; Keller I; Marin D; Müller MJ; Schermuly I; Yakushev I; Albrecht J; Bellhäuser H; Kinateder M; Beck M; Stoeter P
Neurology; 2009 Jan; 72(1):63-8. PubMed ID: 19122032
[TBL] [Abstract][Full Text] [Related]
14. Memory decline in elderly with cerebral small vessel disease explained by temporal interactions between white matter hyperintensities and hippocampal atrophy.
van Leijsen EMC; Tay J; van Uden IWM; Kooijmans ECM; Bergkamp MI; van der Holst HM; Ghafoorian M; Platel B; Norris DG; Kessels RPC; Markus HS; Tuladhar AM; de Leeuw FE
Hippocampus; 2019 Jun; 29(6):500-510. PubMed ID: 30307080
[TBL] [Abstract][Full Text] [Related]
15. High white matter lesion load is associated with hippocampal atrophy in mild cognitive impairment.
Eckerström C; Olsson E; Klasson N; Bjerke M; Göthlin M; Jonsson M; Rolstad S; Malmgren H; Wallin A; Edman A
Dement Geriatr Cogn Disord; 2011; 31(2):132-8. PubMed ID: 21293123
[TBL] [Abstract][Full Text] [Related]
16. The association of regional white matter lesions with cognition in a community-based cohort of older individuals.
Jiang J; Paradise M; Liu T; Armstrong NJ; Zhu W; Kochan NA; Brodaty H; Sachdev PS; Wen W
Neuroimage Clin; 2018; 19():14-21. PubMed ID: 30034997
[TBL] [Abstract][Full Text] [Related]
17. Structural MRI substrates of cognitive impairment in neuromyelitis optica.
Liu Y; Fu Y; Schoonheim MM; Zhang N; Fan M; Su L; Shen Y; Yan Y; Yang L; Wang Q; Zhang N; Yu C; Barkhof F; Shi FD
Neurology; 2015 Oct; 85(17):1491-9. PubMed ID: 26423432
[TBL] [Abstract][Full Text] [Related]
18. Gray matter atrophy is related to long-term disability in multiple sclerosis.
Fisniku LK; Chard DT; Jackson JS; Anderson VM; Altmann DR; Miszkiel KA; Thompson AJ; Miller DH
Ann Neurol; 2008 Sep; 64(3):247-54. PubMed ID: 18570297
[TBL] [Abstract][Full Text] [Related]
19. [Pathophysiological aspects of brain structural disturbances in patients with Fabry disease: literature review].
Nill M; Müller MJ; Beck M; Stoeter P; Fellgiebel A
Fortschr Neurol Psychiatr; 2006 Dec; 74(12):687-95. PubMed ID: 17167727
[TBL] [Abstract][Full Text] [Related]
20. Diffuse structural and metabolic brain changes in Fabry disease.
Marino S; Borsini W; Buchner S; Mortilla M; Stromillo ML; Battaglini M; Giorgio A; Bramanti P; Federico A; De Stefano N
J Neurol; 2006 Apr; 253(4):434-40. PubMed ID: 16541218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
